KIDRON NADAV — SEC Form 4 Insider Trading Activity

Summary

Updated Jul 16, 2026

KIDRON NADAV is a corporate insider tracked by InsiderAlpha. No SEC Form 4 filings recorded in the last 90 days.

Profile

KIDRON NADAV

Nadav Kidron is the President and CEO of Oramed Pharmaceuticals Inc., a company focused on developing oral delivery solutions for therapeutic proteins. He has been instrumental in advancing the company's innovative technologies and product pipeline.

RolePresident and CEO, Director
Notability30/100

Board memberships

Awards & honors

Recent Transactions

DateTickerCompanyCodeSharesPriceValue
2026-03-31ORMPORAMED PHARMACEUTICALS INC.F — Tax withholding / forfeiture44.8K$3.31$148K
2026-03-27LFWDLifeward Ltd.A — Grant or award7.7K$0.00
2026-03-18ORMPORAMED PHARMACEUTICALS INC.A — Grant or award167.0K$0.00
2026-03-16ORMPORAMED PHARMACEUTICALS INC.G — Bona-fide gift100.0K$0.00
2026-01-29ORMPORAMED PHARMACEUTICALS INC.M — Option exercise109.0K$0.00
2026-01-05ORMPORAMED PHARMACEUTICALS INC.A — Grant or award327.0K$0.00
2026-01-05ORMPORAMED PHARMACEUTICALS INC.A — Grant or award232.6K$0.00
2024-11-08ORMPORAMED PHARMACEUTICALS INC.A — Grant or award45.0K—

Frequently Asked Questions

Who is KIDRON NADAV?

Nadav Kidron is the President and CEO of Oramed Pharmaceuticals Inc., a company focused on developing oral delivery solutions for therapeutic proteins. He has been instrumental in advancing the company's innovative technologies and product pipeline.…

Where can I see all of KIDRON NADAV's SEC filings?

All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.

Learn More

Open the live KIDRON NADAV profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.